Advances and challenges of adjuvant treatment in hepatocellular carcinoma
Hepatocellular carcinoma(HCC)is a common malignant tumor in the whole world,and has a high incidence in China.Hepatectomy,physical ablation and liver transplantation are the most effective radical methods for early and middle stage HCC,but the high recurrence rate significantly affects the patients′ overall survival.In recent years,there have been successive breakthroughs in the treatment of advanced HCC,which has stimulated active exploration of adjuvant therapy for HCC.This paper provides a comprehensive review of the current status and progress of adjuvant therapy for HCC,and deeply reflects on the challenges that exist.It is hoped that this paper can provide reference for clinicians.
NETL
NSTL
万方数据
